{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:13:04Z","timestamp":1791684784524,"version":"4.3.4"},"reference-count":45,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T00:00:00Z","timestamp":1515801600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1210\/jc.2017-02426","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T15:27:58Z","timestamp":1515770878000},"page":"1214-1223","source":"Crossref","is-referenced-by-count":73,"title":["Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women"],"prefix":"10.1210","volume":"103","author":[{"given":"Yasir S","family":"Elhassan","sequence":"first","affiliation":[{"name":"Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Idkowiak","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Asia","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom"},{"name":"Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"issue":"9","key":"2019041118372530000_B1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041118372530000_B2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"9","key":"2019041118372530000_B3","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041118372530000_B4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041118372530000_B5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES). American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome: part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"issue":"15","key":"2019041118372530000_B6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJM199410133311502","article-title":"Identification of virilizing adrenal tumors in hirsute women","volume":"331","author":"Derksen","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"2019041118372530000_B7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-09-0576","article-title":"Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma","volume":"162","author":"Dennedy","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041118372530000_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.1.02062","article-title":"Androgen therapy in women","volume":"154","author":"Arlt","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041118372530000_B9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"issue":"14","key":"2019041118372530000_B10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"2019041118372530000_B11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2007-1134","article-title":"Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial","volume":"93","author":"Gurnell","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041118372530000_B12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2008-2374","article-title":"Type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis","volume":"94","author":"Nakamura","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041118372530000_B13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beem.2006.03.007","article-title":"Diagnosis of hyperandrogenism: biochemical criteria","volume":"20","author":"Stanczyk","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2019041118372530000_B14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","article-title":"Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours","volume":"41","author":"Pascale","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041118372530000_B15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/jc.2010-1991","article-title":"Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin","volume":"96","author":"Vollaard","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041118372530000_B16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1373\/49.8.1381","article-title":"Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children","volume":"49","author":"Taieb","year":"2003","journal-title":"Clin Chem"},{"issue":"Pt 1","key":"2019041118372530000_B17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1258\/000456307779595896","article-title":"Measurement of serum testosterone in women; what should we do","volume":"44","author":"Kane","year":"2007","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"2019041118372530000_B18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041118372530000_B19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11154-013-9243-y","article-title":"Revisiting hyper- and hypo-androgenism by tandem mass spectrometry","volume":"14","author":"Fanelli","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2019041118372530000_B20","doi-asserted-by":"crossref","first-page":"e93805","DOI":"10.1371\/journal.pone.0093805","article-title":"Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry","volume":"9","author":"Keefe","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2019041118372530000_B21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.fertnstert.2009.02.056","article-title":"High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms","volume":"94","author":"Di Fede","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"2019041118372530000_B22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/md.0b013e3181946a2c","article-title":"Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2019041118372530000_B23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041118372530000_B24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590801911992","article-title":"Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women","volume":"24","author":"Fanta","year":"2008","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2019041118372530000_B25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041118372530000_B26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041118372530000_B27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.fertnstert.2004.06.040","article-title":"Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis","volume":"82","author":"Glintborg","year":"2004","journal-title":"Fertil Steril"},{"issue":"9","key":"2019041118372530000_B28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2004-821307","article-title":"A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue","volume":"112","author":"Unluhizarci","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"2019041118372530000_B29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2265.1994.tb02535.x","article-title":"A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia","volume":"41","author":"O\u2019Driscoll","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041118372530000_B30","unstructured":"Office for National Statistics. QS201EW - Ethnic Group. Available at https:\/\/www.nomisweb.co.uk\/census\/2011\/QS201EW\/view\/1946157186?cols=measures. Accessed 31 October 2017."},{"issue":"4","key":"2019041118372530000_B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2019041118372530000_B32","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041118372530000_B33","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2015-4009","article-title":"Defining hHyperandrogenism in women with polycystic ovary syndrome: a challenging pPerspective","volume":"101","author":"Pasquali","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041118372530000_B34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.fertnstert.2014.12.105","article-title":"Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome","volume":"103","author":"Alpa\u00f1\u00e9s","year":"2015","journal-title":"Fertil Steril"},{"issue":"3","key":"2019041118372530000_B35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2014-2569","article-title":"Adrenal androgen excess and body mass index in polycystic ovary syndrome","volume":"100","author":"Moran","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118372530000_B36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2019041118372530000_B37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.beem.2004.02.006","article-title":"Dehydroepiandrosterone and ageing","volume":"18","author":"Arlt","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"2019041118372530000_B38","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","author":"Auchus","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041118372530000_B39","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118372530000_B40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","article-title":"A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids","volume":"441","author":"Pretorius","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2019041118372530000_B41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MED.0000000000000334","article-title":"Clinical significance of 11-oxygenated androgens","volume":"24","author":"Turcu","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"2019041118372530000_B42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041118372530000_B43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041118372530000_B44","first-page":"1797","article-title":"Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia","volume":"102","author":"Jones","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041118372530000_B45","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency","volume":"102","author":"Turcu","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/3\/1214\/24263041\/jc.2017-02426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T11:33:53Z","timestamp":1603625633000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/3\/1214\/4801236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,1,12]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02426","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,1,12]]}}}